Literature DB >> 17360971

PDCD10 interacts with Ste20-related kinase MST4 to promote cell growth and transformation via modulation of the ERK pathway.

Xi Ma1, Hongshan Zhao, Jingxuan Shan, Feng Long, Yaoyao Chen, Yingyu Chen, Yingmei Zhang, Xiao Han, Dalong Ma.   

Abstract

PDCD10 (programmed cell death 10, TFAR15), a novel protein associated with cell apoptosis has been recently implicated in mutations associated with Cerebral Cavernous Malformations (CCM). Yeast two-hybrid screening revealed that PDCD10 interacts with MST4, a member of Ste20-related kinases. This interaction was confirmed by coimmunoprecipitation and colocalization assays in mammalian cells. Furthermore, the co-overexpression of PDCD10 and MST4 promoted cell proliferation and transformation via modulation of the extracellular signal-regulated kinase (ERK) pathway. Potent short interfering RNAs (siRNAs) against PDCD10 (siPDCD10) and MST4 (siMST4) were designed to specifically inhibit the expression of PDCD10 and MST4 mRNA, respectively. The induction of siPDCD10 or siMST4 resulted in decreased expression of endogenous PDCD10 or MST4, which was accompanied by reduced ERK activity and attenuated cell growth and anchorage-independent growth. On the other hand, siMST4 had similar effects in PDCD10-overexpressed cells. And more importantly, we confirmed that either overexpressing or endogenous PDCD10 can increase the MST4 kinase activity in vitro. Our results demonstrated that PDCD10 modulation of ERK signaling was mediated by MST4, and PDCD10 could be a regulatory adaptor necessary for MST4 function, suggesting a link between cerebral cavernous malformation pathogenesis and the ERK-MAPK cascade via PDCD10/MST4.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17360971      PMCID: PMC1877091          DOI: 10.1091/mbc.e06-07-0608

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  30 in total

1.  MST4, a new Ste20-related kinase that mediates cell growth and transformation via modulating ERK pathway.

Authors:  J L Lin; H C Chen; H I Fang; D Robinson; H J Kung; H M Shih
Journal:  Oncogene       Date:  2001-10-04       Impact factor: 9.867

2.  HEPSIN inhibits cell growth/invasion in prostate cancer cells.

Authors:  Vasantha Srikantan; Michael Valladares; Johng S Rhim; Judd W Moul; Shiv Srivastava
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

3.  Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock.

Authors:  Mark T Uhlik; Amy N Abell; Nancy L Johnson; Weiyong Sun; Bruce D Cuevas; Katherine E Lobel-Rice; Eric A Horne; Mark L Dell'Acqua; Gary L Johnson
Journal:  Nat Cell Biol       Date:  2003-11-23       Impact factor: 28.824

4.  Mekk3 is essential for early embryonic cardiovascular development.

Authors:  J Yang; M Boerm; M McCarty; C Bucana; I J Fidler; Y Zhuang; B Su
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

5.  Phosphorylation and dimerization regulate nucleocytoplasmic shuttling of mammalian STE20-like kinase (MST).

Authors:  Kyung-Kwon Lee; Shin Yonehara
Journal:  J Biol Chem       Date:  2002-01-22       Impact factor: 5.157

6.  cDNA cloning and expression of an apoptosis-related gene, humanTFAR15 gene.

Authors:  Y Wang; H Liu; Y Zhang; D Ma
Journal:  Sci China C Life Sci       Date:  1999-06

7.  CCM3 mutations are uncommon in cerebral cavernous malformations.

Authors:  D J Verlaan; J Roussel; S B Laurent; C E Elger; A M Siegel; G A Rouleau
Journal:  Neurology       Date:  2005-12-27       Impact factor: 9.910

8.  Gene expression profile of metastatic colon cancer cells resistant to cisplatin-induced apoptosis.

Authors:  Sergio Huerta; Diane M Harris; Ali Jazirehi; Benjamin Bonavida; David Elashoff; Edward H Livingston; David Heber
Journal:  Int J Oncol       Date:  2003-03       Impact factor: 5.650

9.  High-resolution characterization of the pancreatic adenocarcinoma genome.

Authors:  Andrew J Aguirre; Cameron Brennan; Gerald Bailey; Raktim Sinha; Bin Feng; Christopher Leo; Yunyu Zhang; Jean Zhang; Joseph D Gans; Nabeel Bardeesy; Craig Cauwels; Carlos Cordon-Cardo; Mark S Redston; Ronald A DePinho; Lynda Chin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-15       Impact factor: 11.205

10.  The Ste20 kinase MST4 plays a role in prostate cancer progression.

Authors:  Victoria Sung; Wen Luo; Dapeng Qian; Isabelle Lee; Bahija Jallal; Mikhail Gishizky
Journal:  Cancer Res       Date:  2003-06-15       Impact factor: 12.701

View more
  78 in total

1.  Ccm1 regulates microvascular morphogenesis during angiogenesis.

Authors:  Huiling Liu; Daniele Rigamonti; Ahmed Badr; Jun Zhang
Journal:  J Vasc Res       Date:  2010-10-07       Impact factor: 1.934

2.  Molecular recognition of leucine-aspartate repeat (LD) motifs by the focal adhesion targeting homology domain of cerebral cavernous malformation 3 (CCM3).

Authors:  Xiaofeng Li; Weidong Ji; Rong Zhang; Ewa Folta-Stogniew; Wang Min; Titus J Boggon
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

3.  CCDC134 interacts with hADA2a and functions as a regulator of hADA2a in acetyltransferase activity, DNA damage-induced apoptosis and cell cycle arrest.

Authors:  Jing Huang; Li Zhang; Wei Liu; Qinyuan Liao; Taiping Shi; Lin Xiao; Fanlei Hu; Xiaoyan Qiu
Journal:  Histochem Cell Biol       Date:  2012-05-30       Impact factor: 4.304

Review 4.  STRIPAK complexes in cell signaling and cancer.

Authors:  Z Shi; S Jiao; Z Zhou
Journal:  Oncogene       Date:  2016-02-15       Impact factor: 9.867

5.  Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice.

Authors:  Aubrey C Chan; Stavros G Drakos; Oscar E Ruiz; Alexandra C H Smith; Christopher C Gibson; Jing Ling; Samuel F Passi; Amber N Stratman; Anastasia Sacharidou; M Patricia Revelo; Allie H Grossmann; Nikolaos A Diakos; George E Davis; Mark M Metzstein; Kevin J Whitehead; Dean Y Li
Journal:  J Clin Invest       Date:  2011-04-01       Impact factor: 14.808

6.  PDCD10/CCM3 acts downstream of {gamma}-protocadherins to regulate neuronal survival.

Authors:  Chengyi Lin; Shuxia Meng; Tina Zhu; Xiaozhong Wang
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

7.  The kinase MST4 limits inflammatory responses through direct phosphorylation of the adaptor TRAF6.

Authors:  Shi Jiao; Zhen Zhang; Chuanchuan Li; Min Huang; Zhubing Shi; Yanyan Wang; Xiaomin Song; Heng Liu; Chunyang Li; Min Chen; Wenjia Wang; Yun Zhao; Zhengfan Jiang; Hongyan Wang; Catherine C L Wong; Chen Wang; Zhaocai Zhou
Journal:  Nat Immunol       Date:  2015-02-02       Impact factor: 25.606

Review 8.  Recent insights into cerebral cavernous malformations: a complex jigsaw puzzle under construction.

Authors:  Eva Faurobert; Corinne Albiges-Rizo
Journal:  FEBS J       Date:  2010-01-22       Impact factor: 5.542

9.  The MST4-MOB4 complex disrupts the MST1-MOB1 complex in the Hippo-YAP pathway and plays a pro-oncogenic role in pancreatic cancer.

Authors:  Min Chen; Hui Zhang; Zhubing Shi; Yehua Li; Xiaoman Zhang; Ziyang Gao; Li Zhou; Jian Ma; Qi Xu; Jingmin Guan; Yunfeng Cheng; Shi Jiao; Zhaocai Zhou
Journal:  J Biol Chem       Date:  2018-08-02       Impact factor: 5.157

Review 10.  Biology of vascular malformations of the brain.

Authors:  Gabrielle G Leblanc; Eugene Golanov; Issam A Awad; William L Young
Journal:  Stroke       Date:  2009-10-15       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.